Read the first national guidelines for COVID-19 care
Strict criteria is proposed for use of antivirals and other disease-modifying agents
Antimalarials and corticosteroids should not be administered to Australian patients with COVID-19 outside of clinical trials, according to new national guidelines.
Peak Australian health professional bodies, led by the National COVID-19 Clinical Evidence Taskforce, have drafted a suite of evidence-based recommendations in the first consensus national guidelines for COVID-19 care.
